Hutchison, A.

patient study treatment prostatic hyperplasia symptom tamsulosin finasteride combination improvement study period alpha-blocker prostatic phytotherapy therapy hyperplasia period combination therapy point prostate european efficacy country change class reduction visit urology table fi nasteride tract symptoms doxazosin terazosin luts /bph symptom severity management outcome comparison difference medication inhibitor alfuzosin result analysis surgery follow-up number 207–216 pattern triumph 0.0001 tract effect alpha-reductase repen practice group germany serenoa repens italy score ww patients serenoa life practice triumph study nasteride characteristic choice clinician poland pygeum 5- alpha-reductase inhibitors pygeum africanum africanum 4.2 severity 2006 european association flow rate prostate volume farmer rd patient characteristics